Core Scientific (NASDAQ:CORZ) Receives “Buy” Rating from HC Wainwright

Core Scientific (NASDAQ:CORZ)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $25.00 target price on the stock. HC Wainwright’s target price would indicate a potential upside of 51.61% from the company’s previous close.

CORZ has been the topic of several other reports. BTIG Research upgraded Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price objective on the stock in a research report on Tuesday, January 6th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a report on Wednesday, January 21st. Citigroup raised shares of Core Scientific from a “market perform” rating to an “outperform” rating in a research report on Thursday, December 18th. Sanford C. Bernstein raised their target price on shares of Core Scientific from $17.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. Finally, Keefe, Bruyette & Woods boosted their price target on Core Scientific from $19.00 to $25.00 and gave the company a “moderate buy” rating in a report on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $24.47.

Core Scientific Price Performance

Shares of NASDAQ:CORZ opened at $16.49 on Tuesday. The business’s 50 day simple moving average is $17.28 and its 200-day simple moving average is $16.96. The firm has a market capitalization of $5.11 billion, a price-to-earnings ratio of 109.94 and a beta of 6.86. Core Scientific has a 12 month low of $6.20 and a 12 month high of $23.63.

Core Scientific (NASDAQ:CORZ) last posted its earnings results on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.69. The firm had revenue of $79.76 million during the quarter, compared to analyst estimates of $118.45 million. During the same period last year, the company posted ($0.69) EPS. The firm’s revenue for the quarter was down 16.0% on a year-over-year basis. On average, equities analysts anticipate that Core Scientific will post 0.52 earnings per share for the current year.

Institutional Investors Weigh In On Core Scientific

Institutional investors have recently added to or reduced their stakes in the company. Xponance LLC increased its position in shares of Core Scientific by 2.5% in the fourth quarter. Xponance LLC now owns 22,896 shares of the company’s stock worth $333,000 after acquiring an additional 562 shares in the last quarter. Xponance Inc. lifted its stake in shares of Core Scientific by 2.7% during the third quarter. Xponance Inc. now owns 22,334 shares of the company’s stock worth $401,000 after purchasing an additional 595 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Core Scientific by 3.5% in the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 21,029 shares of the company’s stock worth $377,000 after buying an additional 711 shares during the period. CWA Asset Management Group LLC raised its holdings in shares of Core Scientific by 0.3% during the 4th quarter. CWA Asset Management Group LLC now owns 239,937 shares of the company’s stock valued at $3,493,000 after buying an additional 756 shares during the period. Finally, Orion Porfolio Solutions LLC lifted its position in Core Scientific by 5.2% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 15,539 shares of the company’s stock worth $279,000 after acquiring an additional 766 shares in the last quarter.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Colocation revenue surged 268% year-over-year, signaling strong demand for Core Scientific’s high-density hosting business and improved unit economics for its digital infrastructure operations. Core Scientific Colocation Revenue Surges 268% Amid Mixed Q4 Results
• Positive Sentiment: Company-released results and slides show an earnings beat (reported EPS of $0.42 versus consensus of -$0.27) and management emphasized operational progress and RFS (ready-for-service) milestones. Those beats support the view that profitability can improve as colocation scales. Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results
• Neutral Sentiment: Management reiterated a 1.5 GW leasable pipeline (multi-geography builds) as a growth plan — a meaningful long-term positive for capacity and revenue but one that requires capital and execution. Investors are parsing timing and funding. Press Release / Expansion comment
• Neutral Sentiment: The earnings call transcript provides additional color on operations, margin drivers, and RFS timing for facility builds — useful for assessing cadence but not changing the mixed headline. Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous/zeroed-out and is not providing meaningful near-term signal for share pressure. (Treat as noise until validated.)
• Negative Sentiment: Revenue missed expectations materially: reported revenue was ~$79.8M versus analyst estimates near $118.5M, and sales were down ~16% year-over-year — a reminder that top-line recovery lags the profitability signal. Zacks: Key Metrics Versus Estimates
• Negative Sentiment: Some outlets reported Q4 results differently (one flagged a loss), contributing to market confusion and volatility. This inconsistency, combined with the revenue miss, pressured shares. Zacks: Reports Q4 Loss, Misses Revenue Estimates
• Negative Sentiment: Market reaction included an intraday share drop (~2.8% reported by some outlets) as investors weighed expansion risks, revenue shortfall, and the need for capital to scale the 1.5 GW pipeline. Blockonomi: Shares Drop as Company Pushes Forward with 1.5GW Expansion

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.